SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0000921895-19-002559
Filing Date
2019-10-16
Accepted
2019-10-16 12:46:24
Documents
7
Effectiveness Date
2019-10-16

Document Format Files

Seq Description Document Type Size
1 dfan14a12274002_10162019.htm DFAN14A 35115
2 GRAPHIC image_002.jpg GRAPHIC 8864
3 GRAPHIC image_003.jpg GRAPHIC 277087
4 GRAPHIC image_005.jpg GRAPHIC 150962
5 GRAPHIC image_006.jpg GRAPHIC 154020
6 GRAPHIC image_007.jpg GRAPHIC 607296
7 GRAPHIC image_008.jpg GRAPHIC 3098
  Complete submission text file 0000921895-19-002559.txt   1691622
Mailing Address ONE WORLD TRADE CENTER 47TH FLOOR NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER 47TH FLOOR NEW YORK NY 10007 646-975-2500
PROGENICS PHARMACEUTICALS INC (Subject) CIK: 0000835887 (see all company filings)

IRS No.: 133379479 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 000-23143 | Film No.: 191152420
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1055B POWERS PLACE SUITE 810 ALPHARETTA GA 30009
Business Address 5348 VEGAS DR., UNIT 733 LAS VEGAS NV 89108 404-664-3629
Altiva Management Inc. (Filed by) CIK: 0001772491 (see all company filings)

IRS No.: 821992901 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DFAN14A